eSense-Lab Ltd. announce the signing of a distribution and sales agreement with IC ACCESS. eSense has agreed to produce Terpenes profiles and to modify its line of products to suit the unique needs of the UAE market. In addition, the agreement provides for the potential future development of additional joint ventures between the parties for specific applications. The binding agreement signed by IC is for a period of 3 years, with a commitment by IC to purchase Terpene Strains from eSense totaling AUD 1,100,000 with a minimum commitment in the first year (commencing before 30 September 2018) of AUD 366,000. During the term of the agreement, IC will have the exclusive rights to market, sell and distribute eSense products in the UAE. The exclusivity is conditional on meeting the three-year sales commitments described above. In the event that the sales commitments are not met, eSense retains the right, at its sole discretion, to continue the agreement, without the exclusivity status, or elect to terminate the agreement itself.